Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
130.67
-0.78 (-0.60%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Inhibrx Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 124.22 | 152.6 | 277.92 | - | 131.3 | Upgrade
|
| Cash & Short-Term Investments | 124.22 | 152.6 | 277.92 | - | 131.3 | Upgrade
|
| Cash Growth | -18.60% | -45.09% | - | - | 2.05% | Upgrade
|
| Accounts Receivable | - | 0.2 | 0.78 | 0.24 | - | Upgrade
|
| Other Receivables | 0.18 | 0.22 | - | 0.01 | - | Upgrade
|
| Receivables | 0.18 | 0.42 | 0.78 | 0.26 | - | Upgrade
|
| Inventory | 1.88 | 2 | 9.89 | 0.81 | - | Upgrade
|
| Prepaid Expenses | 5.01 | 4.19 | 5.67 | 4.53 | - | Upgrade
|
| Other Current Assets | 1.54 | 1.2 | 1.09 | 0.67 | 7.81 | Upgrade
|
| Total Current Assets | 132.83 | 160.4 | 295.36 | 6.26 | 139.11 | Upgrade
|
| Property, Plant & Equipment | 9.27 | 13.54 | 9.37 | 7.22 | - | Upgrade
|
| Other Long-Term Assets | 4.38 | 6.83 | 3.16 | 3.16 | 11.34 | Upgrade
|
| Total Assets | 146.48 | 180.77 | 307.89 | 16.65 | 150.45 | Upgrade
|
| Accounts Payable | 11.49 | 14.89 | 33.76 | 9.45 | - | Upgrade
|
| Accrued Expenses | 19.99 | 24.25 | 20.49 | 9.46 | - | Upgrade
|
| Current Portion of Leases | 2.33 | 1.6 | 2.06 | 1.86 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 22.45 | Upgrade
|
| Total Current Liabilities | 33.8 | 40.73 | 56.31 | 20.77 | 22.45 | Upgrade
|
| Long-Term Debt | 100.56 | - | 206.97 | - | 70.47 | Upgrade
|
| Long-Term Leases | 4.13 | 6.45 | 1.11 | 3.17 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 5.14 | Upgrade
|
| Total Liabilities | 138.49 | 47.18 | 264.39 | 23.95 | 98.07 | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | -7.3 | 52.38 | Upgrade
|
| Additional Paid-In Capital | 254.18 | 239.72 | 657.23 | - | - | Upgrade
|
| Retained Earnings | -246.19 | -106.13 | -613.73 | - | - | Upgrade
|
| Shareholders' Equity | 7.99 | 133.58 | 43.5 | -7.3 | 52.38 | Upgrade
|
| Total Liabilities & Equity | 146.48 | 180.77 | 307.89 | 16.65 | 150.45 | Upgrade
|
| Total Debt | 107.01 | 8.05 | 210.14 | 5.03 | 70.47 | Upgrade
|
| Net Cash (Debt) | 17.21 | 144.55 | 67.78 | -5.03 | 60.83 | Upgrade
|
| Net Cash Growth | -88.09% | 113.25% | - | - | -38.81% | Upgrade
|
| Net Cash Per Share | 1.11 | 9.65 | 5.75 | -0.13 | 1.60 | Upgrade
|
| Filing Date Shares Outstanding | 14.61 | 14.48 | 13.53 | 43.27 | 38.58 | Upgrade
|
| Total Common Shares Outstanding | 14.58 | 14.48 | 13.53 | 43.27 | 38.58 | Upgrade
|
| Working Capital | 99.03 | 119.67 | 239.05 | -14.51 | 116.66 | Upgrade
|
| Book Value Per Share | 0.55 | 9.23 | 3.22 | -0.17 | 1.36 | Upgrade
|
| Tangible Book Value | 7.99 | 133.58 | 43.5 | -7.3 | 52.38 | Upgrade
|
| Tangible Book Value Per Share | 0.55 | 9.23 | 3.22 | -0.17 | 1.36 | Upgrade
|
| Machinery | 10.08 | 10.31 | 9.02 | 7.55 | - | Upgrade
|
| Construction In Progress | - | - | 3.59 | - | - | Upgrade
|
| Leasehold Improvements | 0.8 | 0.8 | 0.44 | 0.44 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.